Minerva Neurosciences, Inc. Quarterly Share-based Payment Arrangement, Expense in USD from Q1 2014 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Minerva Neurosciences, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q1 2014 to Q3 2024.
  • Minerva Neurosciences, Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $308K, a 17.3% decline year-over-year.
  • Minerva Neurosciences, Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $1.69M, a 26.8% decline year-over-year.
  • Minerva Neurosciences, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $1.97M, a 52.1% decline from 2022.
  • Minerva Neurosciences, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $4.11M, a 21.3% decline from 2021.
  • Minerva Neurosciences, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $5.22M, a 46.2% decline from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $1.69M $308K -$64.2K -17.3% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-05
Q2 2024 $1.75M $329K -$280K -45.9% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-06
Q1 2024 $2.03M $439K +$62.4K +16.6% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-01
Q4 2023 $1.97M $611K -$337K -35.5% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-22
Q3 2023 $2.31M $372K -$665K -64.1% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-05
Q2 2023 $2.97M $609K -$463K -43.2% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-06
Q1 2023 $3.43M $376K -$676K -64.2% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-01
Q4 2022 $4.11M $948K -$257K -21.3% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-22
Q3 2022 $4.37M $1.04M -$77.7K -6.97% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-07
Q2 2022 $4.44M $1.07M -$312K -22.6% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-01
Q1 2022 $4.76M $1.05M -$463K -30.6% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 $5.22M $1.2M -$760K -38.7% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-08
Q3 2021 $5.98M $1.11M -$942K -45.8% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 $6.92M $1.38M -$2.1M -60.3% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 $9.02M $1.52M -$682K -31% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-04
Q4 2020 $9.7M $1.96M -$205K -9.47% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-01
Q3 2020 $9.91M $2.06M -$165K -7.44% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-08
Q2 2020 $10.1M $3.49M +$1.17M +50.2% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-02
Q1 2020 $8.91M $2.2M -$264K -10.7% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-12
Q4 2019 $9.17M $2.17M +$261K +13.7% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-08
Q3 2019 $8.91M $2.22M -$40.6K -1.8% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-02
Q2 2019 $8.95M $2.32M +$423K +22.3% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-03
Q1 2019 $8.53M $2.46M +$348K +16.5% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-04
Q4 2018 $8.18M $1.91M Oct 1, 2018 Dec 31, 2018 10-K 2020-03-09
Q3 2018 $2.26M +$1.03M +83.3% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-04
Q2 2018 $1.9M Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-05
Q1 2018 $2.11M +$814K +62.6% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-06
Q3 2017 $1.23M Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-05
Q1 2017 $1.3M +$500K +62.5% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-03
Q1 2016 $800K +$500K +167% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-04
Q1 2015 $300K $0 0% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-03
Q3 2014 $300K Jul 1, 2014 Sep 30, 2014 10-Q 2014-11-06
Q1 2014 $300K Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.